Menu
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike
Screening Analysis of 24 Elemental Impurity Elements in Drugs Using ICPMS-2040/2050
Applications
| 2024 | Shimadzu
ICP/MS
Instrumentation
ICP/MS
Manufacturer
Shimadzu
Industries
Pharma & Biopharma
Rapid Identification of Polysorbates 20 and 80 Directly Through Amber Bottles
Applications
| 2021 | Agilent Technologies
RAMAN Spectroscopy
Instrumentation
RAMAN Spectroscopy
Manufacturer
Agilent Technologies
Industries
Pharma & Biopharma
Proposed new ICH and USP methods for elemental impurities: The application of ICP-MS and ICP-OES for pharmaceutical analysis
Technical notes
| 2014 | Agilent Technologies
ICP/MS, ICP-OES
Instrumentation
ICP/MS, ICP-OES
Manufacturer
Agilent Technologies
Industries
Pharma & Biopharma
Analysis of Artificial Tear Eye Drops For Elemental Impurities
Applications
| 2022 | Agilent Technologies
ICP/MS
Instrumentation
ICP/MS
Manufacturer
Agilent Technologies
Industries
Pharma & Biopharma
Analysis of Elemental Impurities in Medium- chain Triglycerides According to USP
Applications
| 2022 | Shimadzu
ICP/MS
Instrumentation
ICP/MS
Manufacturer
Shimadzu
Industries
Pharma & Biopharma
ICH Q3D Elemental Impurities Analysis of Tablets by EDX - Verification Based on USP <233> ELEMENTAL IMPURITIES-PROCEDURES
Applications
| 2020 | Shimadzu
X-ray
Instrumentation
X-ray
Manufacturer
Shimadzu
Industries
Pharma & Biopharma
Analysis of Pharmaceutical Raw Materials Compliant with ICH Q3D Guideline Using ICP-MS with Collision/Reaction Mode
Applications
| 2025 | Shimadzu
ICP/MS
Instrumentation
ICP/MS
Manufacturer
Shimadzu
Industries
Pharma & Biopharma
Analysis of Pharmaceutical Raw Materials Compliant with ICH Q3D Guideline Using ICP-MS with Collision Mode
Applications
| 2025 | Shimadzu
ICP/MS
Instrumentation
ICP/MS
Manufacturer
Shimadzu
Industries
Pharma & Biopharma
Other projects
Follow us
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike